by Kong Byeongseon
Published 03 May.2021 07:43(KST)
◆ Chong Kun Dang = Announced Q1 sales of 310.7 billion KRW, a 6.1% increase compared to the same period last year, and operating profit of 22.4 billion KRW, a 14.1% decrease compared to the same period last year.
◆ Mando = Announced Q1 sales of 1.5016 trillion KRW, a 14.6% increase compared to the same period last year, and operating profit of 71.9 billion KRW, a 288.4% increase compared to the same period last year.
◆ Doosan Bobcat = Decided on a debt guarantee of 553.7 billion KRW for Clark Equipment Co.
◆ Kiwoom Securities = Decided to increase short-term borrowings by 200 billion KRW.
◆ Samsung Electronics = Changed the largest shareholder from Lee Kun-hee and 13 others to Samsung Life Insurance and 14 others due to inheritance reasons.
◆ Hyosung TNC = Announced Q1 sales of 1.6182 trillion KRW, a 16.6% increase compared to the same period last year, and operating profit of 246.8 billion KRW, a 214.4% increase compared to the same period last year.
◆ Hyosung Advanced Materials = Announced Q1 sales of 769.5 billion KRW, an 11.82% increase compared to the same period last year, and operating profit of 83.4 billion KRW, a 192.92% increase compared to the same period last year.
◆ Hyosung = Announced Q1 sales of 686.9 billion KRW, a 9% increase compared to the same period last year, and operating profit of 100.6 billion KRW, a 1788% increase compared to the same period last year.
◆ Daehan Electric Wire = Announced Q1 sales of 391.7 billion KRW, a 7.91% increase compared to the same period last year, and operating profit of 1.7 billion KRW, a 79.07% decrease compared to the same period last year.
◆ Sewon Precision = Korea Exchange to hold and resume deliberations of the Corporate Evaluation Committee to review the company’s continued listing eligibility.
◆ Asendio = Korea Exchange announced the decision to maintain the company’s listing and lifted the trading suspension.
◆ Celltrion = Received domestic MFDS approval for Phase 3 clinical trial plan of CT-P42 (Eylea biosimilar).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.